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7,353 and 25,500 ill returned traveler encounters respec-
ively at globally dispersed travel or tropical medicine
linics, between 1996 and 2006, the dermatosis were the
hird reason for consultation in frequency, after fever and
iarrhoeal illness, and represented 17-18% of all diagnoses.
Independently of these studies and other series, der-
atoses are likely to have higher incidence because they
ften resolve spontaneously or sometimes the patients
equire medical assistance outside the Travel medicine
r Tropical disease units which have conducted the most
esearch on these topics.
In assessing dermatoses in travelers, it is important to
onsider some factors such as the geographical destination
isited,places visited en route, length of stay, purpose of
ravel and activities.
Dermatoses can be noninfectious and infec-
ious/infestation, which can be cosmopolitan or from
ropical origin.
The most common diagnoses are cutaneous larva
igrans, soft tissue bacterial infection, arthropod bite,
llergic reaction, myiasis, cutaneous leishmaniasis and tun-
iasis.
It is important to remember that skin lesions may be man-
festations of systemic infectious diseases such as dengue
ash, Chicungunya viruses, rickettsial infection, or non-
nfectious diseases such as those related to previous medical
istory, drug allergies, climate or sea related dermatoses.
Appropriate investigations and consultation with tropical
r tavel medicine experts may be needed in order to make
he correct diagnosis and provide correct management of
hese diseases. It is also necessary to emphasize preventive
easures related to skin diseases in pre-travel advice.
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In the last four decades new infectious diseases have
een recognized almost every year, assuring emerging infec-
ious diseases (EID) as a priority for global health. Some
f these diseases, such as AIDS, SARS and the inﬂuenza
andemic, have threatened the global health due to their
apacity to cross geopolitical boundaries. To respond to
his new scenario the countries afﬁliated with the World
ealth Organization (WHO) approved a new revision of the
nternational Health Regulations (IHR) in 2005. The IHR is
a
u
p
tternational Congress on Infectious Diseases (ICID) Abstracts
binding legal instrument, which aim to provide a proper
ublic health response to the international spread of dis-
ase avoiding unnecessary interference with international
rafﬁc and trade. The new IHR, which have been enforced
ince June 2007, holds a broader framework, shifting its
ocus from a small list of notiﬁable diseases to any event
hat can become a public health emergency of international
oncern (PHEIC). Furthermore, the new IHR established a
lobal sensitive mechanism to detect PHEICs using both ofﬁ-
ial notiﬁcation and media news.
The study analyses the events considered as potential
nternational concern for the Americas under the IHR 2005
ramework, from June 2007 to December 2009. The source of
ata was the World Health Organization Event Management
ystem (WHO-EMS).
During the period studied, 243 events were considered as
HEIC in the region of the Americas.
Despite the political commitment provided by the coun-
ries to approve the new IHR, 39.9% were initially detected
hrough news media and 30.0% were notiﬁed by the National
ocal Point (NFP) within the Ministries of Health. These ﬁg-
res reﬂect the countries’ remaining tendency to hold the
otiﬁcation until ﬁnishing the veriﬁcation process. 189/243
77.8%) were infectious disease outbreaks, 8.2% were food
afety events and 7.8% were animal health (epizootics)
vents. The study analyzes the main characteristics of these
vents and their implication for global health.
The IHR 2005 provides a useful framework for early detec-
ion and risk assessment of EID with potential international
pread. Each country needs to accomplish the core capaci-
ies to perform surveillance and response activities in order
o strengthen the global health security.
oi:10.1016/j.ijid.2010.02.1489
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Immunization of travelers is a very important challenge
or travel medicine practitioners. It should be tailored to
ach particular situation. Destination, duration of stay,
ctivities and individual health, among others, inﬂuence
hese recommendations. The key point is to determine the
ravel risk. Selection of recommended immunizations should
e based on epidemiological evidence, taking into account
ncidence rates and severity of certain infections. Other
actors to inﬂuence recommendations include: time, shots,
vailability, costs, interactions and vaccine side effects. Yel-
ow fever remains the only required vaccine by Who. Special
equirements are taken for those pilgrims on Hajj, where
accination against meningococcal ACWY is mandatory and
lso polio vaccine is required to some travelers.
Routine vaccines are always updated in pre travel eval-
ation. Inﬂuenza remains one of the most frequent vaccine
reventable infections. Recommended immunization for
ravelers includes common vaccine preventable diseases, as
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the main food and drinks related infections like hepatitis
A and typhoid fever, as well as the life threatening disease
rabies. Protection against hepatitis B is high through vacci-
nation and should be considered in long term and frequent
travelers. Our experience in Travel Vaccines will be showed.
doi:10.1016/j.ijid.2010.02.1490
06.002
Routine Immunization
A. Rísquez Parra
Universidad Central de Venezuela, Department of Preven-
tive and Social Medicine, Caracas, Venezuela
Routine immunization has become among the most com-
mon preventive tools use by medical practitioners all over
the World. Vaccinations have proven to eradicated and con-
trol many preventable diseases such as smallpox, polio,
measles, tetanus and diphtheria among others. Globally,
children vaccines calendars are most familiar for all devel-
oped and underdeveloped countries. However, only until
recently that adolescents and adult vaccinations are known
for many underdeveloped countries. Travel medicine is a
good way to promote immunization calendars for all and
should be a goal for our performance because there is an
intrinsic synergistic relationship between them. The World
Health Organization (WHO) has an important role in rec-
ommending routine immunizations for all groups of ages
(children, adolescents and adults), diverse regions, and cer-
tain risk populations. WHO initial main program was the
Expanded Program in Immunization which included vaccines
for the maternal and children population under one year
of age. Now among other goals are integrating immuniza-
tions’ in the health systems and immunizing within a global
health interdependence context are global objectives. Most
countries follow the basic program for children and must
comply with mandatory travel vaccines by the new Inter-
national Health Regulations (2005). However, still the risk
of lifethreatening illness is very high especially in under-
developed regions because still the vaccines coverage is
low, therefore; the risk for reemerging diseases and spread-
ing consequently with illnesses, disability and deaths. Also,
there are new technologies and vaccines available which
make difﬁcult to ﬁnancially provide the service for all. New
biological products developments and technologies, vac-
cines primary series, interval of doses, and boosters must
be learned by travel medicine practitioners. Also, adverse
reactions and contraindications, particularly for those trav-
elers with special needs or conditions in order to provide
good advice during their pre-travel consultation.
doi:10.1016/j.ijid.2010.02.1491
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.S. Chaves
Institute for Infectious Diseases Emilio Ribas, Sao Paulo,
razil
Individuals travel for many reasons, including holidays,
ecreation, business, visiting friends and relatives, health
reatments, educational experiences or others purposes.
he World Tourism Organization predicts that international
ourist travel may top 1 billion by 2010. Given the growth of
nternational travel, the area travel medicine has expanded
f the worldwide. The vaccination is one of the steps that
ealth providers for giving travelers, and the vaccines rec-
mmended prior to international travel can be divided into
hree fases: those that are routine, those that may be
equired and those that are recommended on the basis an
ndividual risk assessment for the traveler. Considerations in
hoosing vaccines include destination; season and duration
f travel; activities planned; severity of disease; whether
he trip will be urban, rural, or remote from medical care;
ime remaining before departure; vaccine availability, cost,
nd the number of doses needed; history of allergy to
accines or their components; medications currently being
aken; pregnancy; chronic illness; and underlying medical
onditions such as a compromised immune system. Vac-
ines recommended for travelers and that will be discussed:
holera, hepatitis A, Typhoid fever, Japanese encephalitis,
eningococcal disease, rabies and Tick-borne encephali-
is. Conclusion: Vaccination is a highly effective method
f preventing certain infectious diseases. Travel medicine
ractitioners must be care when to evaluate immunization
tatus of the traveler with goal to consider or not to vaccine
or patient. Travelers should be informed about the risks of
ontracting disease, as well as, the risks of adverse events
rom immunizations.
oi:10.1016/j.ijid.2010.02.1492
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The purpose of this talk is to brieﬂy address some high-
ights about the illness and its burden in relation to travel,
ew epidemiological aspects, particularly focusing on the
aribbean and South American situation in 2008-9. Concep-
ual points regarding yellow fever vaccine will be reviewed,
ocusing specially on severe adverse events described in the
ast 10 years, which have put the actual vaccine risk/beneﬁt
elation under close scrutiny. Some practical situations
egarding its indication that could lead to controversy will
e also discussed.
oi:10.1016/j.ijid.2010.02.1493
